 LOS ANGELES--BUSINESS WIRE--- ACRX CLASSACTION--Glancy Prongay Murray LLP GPM reminds investors of the upcoming August 9, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired AcelRx Pharmaceuticals, Inc. AcelRx or the Company NASDAQ: ACRX securities between March 17, 2020 and February 12, 2021, inclusive the Class Period. If you suffered a loss on your AcelRx investments or would like to inquire about potentially 